Replication mechanism of human prions
人类朊病毒的复制机制
基本信息
- 批准号:10330439
- 负责人:
- 金额:$ 51.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AmyloidBindingBiologic CharacteristicBiological AssayBovine Spongiform EncephalopathyCattleChronic Wasting DiseaseCreutzfeldt-Jakob SyndromeDataDeerDeuteriumDevelopmentDiseaseEvolutionFoundationsGrowthHeterogeneityHumanHydrogenHydroxyl RadicalInfectious AgentLaboratoriesLeadLightLinkMethodsModelingMolecularMolecular ConformationMusMutationNatureNerve DegenerationNeurodegenerative DisordersPathogenesisPathogenicityPathologyPeptide HydrolasesPhenotypePlayPrPPrPSc ProteinsPrion DiseasesPrionsProcessPropertyProteinsPublishingResearchResistanceRodentRoleSeedsSignal TransductionStructureSucroseSymptomsTechniquesTestingTimeToxic effectTransgenic Micebaseconformational conversionconformerdisease phenotypein vivoinsightnovelnovel strategiesnovel therapeutic interventionprotein aggregationprotein misfolding cyclic amplificationsedimentation velocitytoolyeast prion
项目摘要
ABSTRACT
Prions are unique, protein-only infectious agents that are responsible for a group of fatal neurodegenerative
diseases such as Creutzfeldt-Jakob disease in humans, bovine spongiform encephalopathy in cattle and
chronic wasting disease in deer and elk. Human prion diseases are especially poorly understood, largely due
to their vast phenotypic heterogeneity that arises from a large spectrum of diverse human prion strains. It is
generally accepted that the prion agent multiplies by binding to normal prion protein (PrPC) and converting it
into a conformationally distinct pathogenic molecule (PrPSc), but the mechanism of this process remains
unclear. A growing number of studies suggest a critical role in prion disease pathogenesis of small, relatively
protease sensitive oligomers that appear to control two fundamental steps in the disease pathogenesis: prion
replication rate and toxicity. One of the primary objectives of the proposed research is to advance molecular
level understanding of the properties of oligomeric PrPSc (oPrPSc) and the mechanism by which these
oligomers contribute to the pathogenic process in different phenotypes of sporadic Creutzfeldt-Jakob disease
(sCJD). The first Specific Aim is to characterize the structural organization of oPrPSc and define the role of this
organization in the replication, propagation and toxicity of the most common strains of sCJD. The second Aim
is to identify early critical conformational steps in the interaction between PrPC and oPrPSc, the steps that likely
play a major role in triggering toxic signaling, creating human prions and controlling prion evolution. If
successful, the proposed studies should not only shed new light on the pathogenic mechanism in human prion
disorders, but also provide a basis for understanding the relationship between PrPSc structure and strain
properties of human prions.
抽象的
prion是独特的,仅蛋白质的感染剂,负责一组致命的神经退行性
诸如人类的克鲁特兹菲尔特 - 贾科布疾病,牛的海绵状脑病和牛的疾病
鹿和麋鹿中的慢性浪费疾病。人类pr疾病尤其知之甚少,很大程度上是由于
它们的巨大表型异质性是由各种各样的人类pr菌菌株引起的。这是
普遍认为,prion剂通过与正常prion蛋白(PRPC)结合而乘以其转换
进入构象上不同的致病分子(PRPSC),但该过程的机制仍然存在
不清楚。越来越多的研究表明,在小型,相对较小的病毒疾病发病机理中起关键作用
蛋白酶敏感的低聚物似乎控制了疾病发病机理的两个基本步骤:prion
复制率和毒性。拟议研究的主要目标之一是提高分子
对寡聚PRPSC(OPRPSC)的性质的水平了解和这些机制
低聚物在不同表型中造成了致病过程
(SCJD)。第一个具体目的是表征OPRPSC的结构组织,并定义了这一点的作用
SCJD最常见菌株的复制,传播和毒性的组织。第二个目标
是确定PRPC与OPRPSC之间相互作用的早期关键构象步骤,这可能
在触发有毒信号,创造人王和控制王室演变方面发挥重要作用。如果
成功的研究不仅应为人类prion的致病机制提供新的启示
疾病,但也为理解PRPSC结构与应变之间的关系提供了基础
人王室的特性。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Chronic wasting disease (CWD) prion strains evolve via adaptive diversification of conformers in hosts expressing prion protein polymorphisms.
慢性消耗性疾病(CWD)朊病毒株通过表达朊病毒蛋白多态性的宿主中构象异构体的适应性多样化而进化。
- DOI:10.1074/jbc.ra120.012546
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:DuqueVelásquez,Camilo;Kim,Chae;Haldiman,Tracy;Kim,Chiye;Herbst,Allen;Aiken,Judd;Safar,JiriG;McKenzie,Debbie
- 通讯作者:McKenzie,Debbie
Cortical and bithalamic hypometabolism by FDG-PET/CT in a patient with sporadic fatal insomnia.
FDG-PET/CT 检测散发性致命性失眠患者的皮质和双丘脑代谢低下。
- DOI:10.1212/wnl.0000000000007240
- 发表时间:2019
- 期刊:
- 影响因子:9.9
- 作者:Haight,Taylor;Mendiola,Cecelia;Solnes,Lilja;Cohen,Mark;Safar,Jiri;Schonberger,LawrenceB;Probasco,JohnC
- 通讯作者:Probasco,JohnC
Variably Protease-sensitive Prionopathy in a Middle-aged Man With Rapidly Progressive Dementia.
- DOI:10.1097/wnn.0000000000000276
- 发表时间:2021-09-02
- 期刊:
- 影响因子:0
- 作者:Huang J;Cohen M;Safar J;Auchus AP
- 通讯作者:Auchus AP
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WITOLD K SUREWICZ其他文献
WITOLD K SUREWICZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WITOLD K SUREWICZ', 18)}}的其他基金
Structural diversity of cervid prions and phenotypic variation of chronic wasting disease
鹿朊病毒的结构多样性和慢性消耗性疾病的表型变异
- 批准号:
10657957 - 财政年份:2023
- 资助金额:
$ 51.81万 - 项目类别:
BIOPHYSICAL PROPERTIES OF PRION PROTEIN OLIGOMERS
朊病毒蛋白低聚物的生物物理特性
- 批准号:
7277489 - 财政年份:2007
- 资助金额:
$ 51.81万 - 项目类别:
相似国自然基金
DMWD结合LATS1通过负向调控Hippo-YAP信号通路促进恶性胶质瘤干性的分子机制
- 批准号:82302980
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
异戊二烯化修饰Rac3结合PKD2/Arfaptin-2复合体介导MMP1/2囊泡分泌促进头颈鳞癌侵袭转移的机制研究
- 批准号:82303507
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多组学探究RNA结合蛋白RBM22在5q-综合征中的功能与机制
- 批准号:
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:
结合诱导纤维生成肽长效抑制角膜新生血管形成治疗角膜病的机制
- 批准号:
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:
污水处理系统结合态雌激素的生物转化机制与风险削减研究
- 批准号:52370200
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
相似海外基金
The role of extracellular vesicles in keratoconus pathogenesis
细胞外囊泡在圆锥角膜发病机制中的作用
- 批准号:
10595121 - 财政年份:2023
- 资助金额:
$ 51.81万 - 项目类别:
Evaluating unique aspects of quiescent ovarian cancer cell biology for therapeutic targets
评估静息卵巢癌细胞生物学的独特方面以寻找治疗靶点
- 批准号:
10750118 - 财政年份:2023
- 资助金额:
$ 51.81万 - 项目类别:
Probing neuroinflammation in Alzheimer's disease with NLRP3 PET radiotracers
使用 NLRP3 PET 放射性示踪剂探测阿尔茨海默病的神经炎症
- 批准号:
10659920 - 财政年份:2023
- 资助金额:
$ 51.81万 - 项目类别:
Exposing the role of MYC in small cell carcinoma of the ovary hypercalcemic type
揭示 MYC 在卵巢高钙血症型小细胞癌中的作用
- 批准号:
10728702 - 财政年份:2023
- 资助金额:
$ 51.81万 - 项目类别:
Development of NLRP3 inflammasome inhibitors for intervening in Alzheimer's disease
开发NLRP3炎症小体抑制剂干预阿尔茨海默病
- 批准号:
10766380 - 财政年份:2022
- 资助金额:
$ 51.81万 - 项目类别: